Kite Readies A Second CAR-T For Filing As CD19 Competition Grows

 
• By Mandy Jackson
  
T Cell lymphocyte with receptors for cancer cell immunotherapy research 3D render
Kite will soon seek approval for its second T-cell therapy. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D